Image of the Day: Meiosis Researcher, Olympic Hopeful

Olivia Ballew, a graduate student at Indiana University, is currently writing her dissertation while preparing to compete in the upcoming Olympic marathon trials.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Olivia Ballew knows the difficulties of both science and running, but “if I had to pick,” she tells The Scientist, “I would say that getting a PhD is much harder than qualifying for the Olympic Trials.”

It was Ballew’s time in the Indianapolis Monumental Marathon in November 2018—2:43:15—that qualified her to compete in the Olympic trials to be held later this week in Atlanta. The top runners will advance to the summer Olympics in Tokyo this July. Ballew has been training for the run as she simultaneously writes her dissertation on meiotic commitment in yeast cells.

Her research in Soni Lacefield’s lab at Indiana University investigates what keeps a cell in meiosis once it decides to undergo the process, and she has found that knocking out two meiotic checkpoints—one in yeast cells and another in mammalian cells—results in a loss of meiotic commitment.

As the trials approach, she has been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Amy Schleunes

    A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution